Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'angiotensin receptor blockers' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 44 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. White, WB
      Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate

      BLOOD PRESSURE MONITORING
    2. Neutel, JM
      The importance of 24-h blood pressure control

      BLOOD PRESSURE MONITORING
    3. White, WB
      Controlling blood pressure with combination therapy: the role of angiotensin II receptor blockers combined with diuretics

      BLOOD PRESSURE MONITORING
    4. Mann, J; Oddou, P
      Ongoing clinical trials in systemic hypertension

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    5. Sharkey, LC; Holycross, BJ; McCune, SA; Radin, MJ
      Obese female SHHF/Mcc-fa(cp) rats resist antihypertensive effects of renin-angiotensin system inhibition

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    6. Parving, HH
      Hypertension and diabetes: the scope of the problem

      BLOOD PRESSURE
    7. Donnelly, S
      Why is erythropoietin made in the kidney? The kidney functions as a critmeter

      AMERICAN JOURNAL OF KIDNEY DISEASES
    8. Carson, P; Giles, T; Higginbotham, M; Hollenberg, N; Kannel, W; Siragy, HM
      Angiotensin receptor blockers: Evidence for preserving target organs

      CLINICAL CARDIOLOGY
    9. Textor, SC; Wilcox, CS
      Renal artery stenosis: A common, treatable cause of renal failure?

      ANNUAL REVIEW OF MEDICINE
    10. Komers, R; Komersova, K
      Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    11. Auslender, M; Artman, M
      Overview of the management of pediatric heart failure

      PROGRESS IN PEDIATRIC CARDIOLOGY
    12. Elliott, WJ
      When will the ACE-inhibitors be declared obsolete?

      JOURNAL OF HUMAN HYPERTENSION
    13. Israili, ZH
      Clinical pharmacokinetics of angiotensin II (AT(1)) receptor blockers in hypertension

      JOURNAL OF HUMAN HYPERTENSION
    14. Kaplan, NM
      Angiotensin II-receptor blockers: will they replace angiotensin-convertingenzyme inhibitors in the treatment of hypertension?

      JOURNAL OF HUMAN HYPERTENSION
    15. Puscas, I; Coltau, M; Gilau, L; Baican, M; Pasca, R; Domuta, G; Hecht, A
      The mechanism of action of angiotensin II is dependent on direct activation of vascular smooth muscle carbonic anhydrase I

      INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
    16. Siragy, HM
      The role of the AT(2) receptor in hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    17. Oparil, S
      Newly emerging pharmacologic differences in angiotensin II receptor blockers

      AMERICAN JOURNAL OF HYPERTENSION
    18. Gavras, H
      Update on the clinical pharmacology of candesartan cilexetil

      AMERICAN JOURNAL OF HYPERTENSION
    19. Hollenberg, NK
      The renin-angiotensin system and cardiovascular disease

      BLOOD PRESSURE
    20. Johnston, CI
      Angiotensin II type 1 receptor blockade: a novel therapeutic concept

      BLOOD PRESSURE
    21. Unger, T
      Differences among angiotensin II type 1 receptor blockers: Characteristicsof candesartan cilexetil

      BLOOD PRESSURE
    22. Sever, PS
      Improving antihypertensive efficacy while maintaining placebo-like tolerability

      BLOOD PRESSURE
    23. Meredith, P
      Achieving quality 24-h blood pressure control with candesartan cilexetil

      BLOOD PRESSURE
    24. Ruilope, L
      Improving prognosis in hypertension: Exploring the benefits of angiotensinII type 1 receptor blockade

      BLOOD PRESSURE
    25. Swedberg, K
      Exploring new treatment strategies in heart failure

      BLOOD PRESSURE
    26. Siragy, HM
      AT(1) and AT(2) receptors in the kidney: Role in disease and treatment

      AMERICAN JOURNAL OF KIDNEY DISEASES
    27. Schrier, RW
      Treating high-risk diabetic hypertensive patients with comorbid conditions

      AMERICAN JOURNAL OF KIDNEY DISEASES
    28. Jamerson, KA
      Rationale for angiotensin II receptor blockers in patients with low-renin hypertension

      AMERICAN JOURNAL OF KIDNEY DISEASES
    29. Lacourciere, Y
      A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged >= 65 years with mild to moderate hypertension

      CLINICAL THERAPEUTICS
    30. Shvetsov, MY
      Angiotensin II receptor blockers - pilot experience and nephrological perspectives

      TERAPEVTICHESKII ARKHIV
    31. Cohn, JN; Tognoni, G; Glazer, RD; Spormann, D; Hester, A
      Rationale and design of the Valsartan Heart Failure Trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

      JOURNAL OF CARDIAC FAILURE
    32. Thai, H; Raya, T
      Angiotensin II receptor blockers

      CORONARY ARTERY DISEASE
    33. Weber, MA
      Interrupting the renin-angiotensin system: The role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    34. Zusman, RM
      Are there differences among angiotensin receptor blockers?

      AMERICAN JOURNAL OF HYPERTENSION
    35. Neutel, JM; Smith, DHG
      Hypertension control: Multifactorial contributions

      AMERICAN JOURNAL OF HYPERTENSION
    36. Willenheimer, R; Dahlof, B; Rydberg, E; Erhardt, L
      AT(1)-receptor blockers in hypertension and heart failure: clinical experience and future directions

      EUROPEAN HEART JOURNAL
    37. Schwenger, V; Zeier, M; Ritz, E
      Antihypertensive therapy in renal patients - Benefits and difficulties

      NEPHRON
    38. PYLYPCHUK GB
      ACE-INHIBITOR - VERSUS ANGIOTENSIN-II BLOCKER-INDUCED COUGH AND ANGIOEDEMA

      The Annals of pharmacotherapy
    39. WICHER G; BIEWALD GA
      PERIPHERAL ANGIOTENSIN-II RECEPTORS OF THE AT1 SUBTYPE MEDIATE THE MODULATION OF VAGAL EFFECTS ON CARDIAC FUNCTIONS IN ISOLATED RAT HEARTS

      Zoology
    40. RITZ E; MILTENBERGERMILTENYI G; WAGNER J; RYCHLIK I
      DIABETES - RENAL-FUNCTION - WHAT ARE THE SPECIAL PROBLEMS

      Basic research in cardiology
    41. TRENKWALDER P
      EFFECTS OF CANDESARTAN CILEXETIL ON GLUCOSE-HOMEOSTASIS

      Basic research in cardiology
    42. WEBER MA
      COMPARISON OF TYPE-1 ANGIOTENSIN-II RECEPTOR BLOCKERS AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE TREATMENT OF HYPERTENSION

      Journal of hypertension
    43. ODONNELL MP; CRARY GS; ODA H; KASISKE BL; POWELL JR; KEANE WF
      IRBESARTAN LOWERS BLOOD-PRESSURE AND AMELIORATES RENAL INJURY IN EXPERIMENTAL NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      Kidney international
    44. DZAU VJ
      MOLECULAR-BIOLOGY OF ANGIOTENSIN-II BIOSYNTHESIS AND RECEPTORS

      Canadian journal of cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/02/20 alle ore 14:28:46